We found a slight trend of increasing risk of BCC among the users of glucocorticoids with longer duration of use, with IRRs increasing to 1.17 (95% CI: 1.08–1.28) among recorded users of more than 1 year, and to 1.22 (95% CI: 1.09–1.36) among recorded users of more than 5 years before the diagnosis date ( Table 2 ).
← all excerpts
Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
1
—
—